Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison

Lebrikizumab plus TCS was comparable to dupilumab plus TCS across all efficacy endpoints at week 16.

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-12-20
DOI
https://doi.org/10.1007/s13555-025-01620-x
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison

Martín Dossenbach, Bülent Akmaz, Gaia Gallo, Yousef Binamer et al.
Dermatology and Therapy
Dermatology and Skin Diseases
article

Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison

Martín Dossenbach, Bülent Akmaz, Gaia Gallo, Yousef Binamer, Raj Chovatiya, L. Puig, Mark G. Kirchhof, Yuxin Ding, Leon Kircik, Chao Yang, Gleison Vieira Duarte, Tiago Torres, Lucia Seminario‐Vidal, April W. Armstrong, Jonathan I. Silverberg
article en

Abstract

Lebrikizumab plus TCS was comparable to dupilumab plus TCS across all efficacy endpoints at week 16.

Dermatology and TherapyVol. 16(2)
University of Southern California (US), Alfaisal University (SA), University of Ottawa (CA), Eli Lilly (United States) (US), Universidade do Porto (PT), Rosalind Franklin University of Medicine and Science (US), George Washington University (US), Instituto Federal de Educação, Ciência e Tecnologia Baiano (BR), Ottawa Hospital (CA), King Faisal Specialist Hospital & Research Centre (SA), Hospital de Sant Pau (ES), Almirall (Spain) (ES), Hospital de Santo António (PT), Center for Clinical Research (United States) (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), Icahn School of Medicine at Mount Sinai (US)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Biogen, Celgene, Canadian Dermatology Foundation, Valeant Pharmaceuticals International, Celldex Therapeutics, Mylan, Castle Biosciences, Galderma, Sun Pharma, LEO Pharma, Samsung
Openalex Percentile: Top 35%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.